VHL, 17
DM, 14
tumor, 12
tumour, 9
HD, 8
cancer, 6
breast cancer, 6
ataxia-telangiectasia, 5
WAS, 5
AT, 5
Atm-deficient, 4
ND, 4
A-T, 4
male breast cancer, 4
breast-ovarian cancer, 3
SJS, 3
lipoma, 3
galactosemia, 3
breast / ovarian cancer, 2
APC, 2
breast or ovarian cancer, 2
myotonic dystrophy, 2
HPRT-deficient, 2
PAH-deficient, 2
hereditary breast and ovarian cancer, 2
CHD, 2
RCC, 2
breast and ovarian cancer, 2
EDMD, 1
von Hippel-Lindau tumor, 1
Wiskott-Aldrich syndrome, 1
familial breast cancer, 1
alkaptonuria, 1
colorectal cancer, 1
EMDM, 1
HPRT-APRT-deficient, 1
HNPCC, 1
AAPC, 1
G6PD deficient, 1
retinoblastoma, 1
von Hippel-Lindau ( VHL ) disease, 1
ovarian cancer, 1
C6-deficient, 1
prostatic adenocarcinoma, 1
glioblastoma, 1
APRT-HPRT-deficient, 1
inherited breast cancer, 1
ACG1B, 1
multiple endocrine neoplasia ( MEN ) types 1 and 2, 1
familial aniridia, 1
hereditary breast cancer, 1
hereditary nonpolyposis colorectal cancer, 1
diastrophic dysplasia, 1
prostate adenocarcinoma, 1
inherited breast / ovarian cancer, 1
hereditary breast or ovarian cancer, 1
FED, 1
prostate cancer, 1
MEN2, 1
insulin-dependent diabetes mellitus, 1
breast and 79 ovarian cancer, 1
adenomatous polyposis coli, 1
aniridia, 1
MEN1, 1
C7-deficient, 1
C9 deficiency, 1
AO-GLD, 1
Emery-Dreifuss muscular dystrophy, 1
endometrial carcinoma, 1
pancreatic tumour, 1
von Willebrand, 1
